STARD7 overexpression was also detected at the protein level in all our tested clinical cases of TNBCs as well as in most ER+ tumors (infiltrating ductal carcinomas) (Figure 1G). This evidence concerns the gene ESR1 and invasive ductal breast carcinoma.